ABOUT US

LynxDx, Inc. is a privately held pre-revenue diagnostic company headquartered in Ann Arbor, Michigan, with research facilities just a few miles away from the University of Michigan Health System. LynxDx currently is focused on commercializing diagnostic tools, including a diagnostic qPCR assay for COVID-19 and a urine assay to aid in diagnosis of prostate cancer (MyProstateScore).  We currently operate a CLIA-licensed high-complexity molecular diagnostics laboratory that serves to commercially provide our diagnostic assays.

WHITE LOGO.PNG
INFORMATION
CONTACT